Evidence · idea-013

21 CFR (Title 21 of the Code of Federal Regulations) 876.5030 classifies a "continent ileostomy catheter" — described as a flexible tubular device used as a form during surgery for continent ileostomy, providing drainage after surgery, that may also be inserted periodically by the patient for routine care to empty the ileal pouch — as Class I, exempt from premarket notification (510(k) (premarket notification)) procedures under subpart E of 21 CFR part 807, subject to the limitations in 21 CFR 876.9.

A competitor, Ampa Medical (Copenhagen, Denmark), is developing "InterPoc," an investigational absorbent device ("intestinal tampon") intended to be advanced past the stoma into the small bowel, that expands as it absorbs liquid stool and is removed by pulling an attached elastic string; a pilot safety/tolerability study with Aarhus University Hospital reported the device was safe and well tolerated in adults with an ileostomy over a 24-hour follow-up period, with results appearing in a British Journal of Nursing article.

Between approximately 725,000 and 1,000,000 Americans are living with an ostomy (any type — colostomy, ileostomy, or urostomy), and approximately 100,000 new ostomy surgeries are performed annually in the United States.

Reported leakage incidence among people living with an ostomy ranges from 18% to 76% across published studies, with roughly 37% of those experiencing leakage reporting it at least once per week; separately, over 81% of those who experienced leakage also reported peristomal skin irritation.

HCPCS codes A4361 (a HCPCS code for a supply) through A4438 constitute an established billing category ("Ostomy Pouches and Supplies") covering existing external pouching-system components (e.g. A4416, ostomy pouch, closed, with barrier attached, with filter, 1-piece; A4362, ostomy skin barrier, solid 4x4 or equivalent), administered under Medicare DMEPOS (durable medical equipment, prosthetics, orthotics and supplies) with a published fee schedule.

The U.S. ostomy care and accessories market generated approximately $586.6 million in revenue in 2025 (one market-research estimate; other published estimates for differently scoped "ostomy/stoma care" categories, some global, range from roughly $3.5B to $4.3B).

US Patent 11,395,757 B2, "Continent ostomy valve and method of use," is a live, recently-issued US patent covering a continent-ostomy valve device and method — a potential freedom-to-operate concern for any device using a mechanical valve at a stoma, including this candidate's mechanism, and its claims scope was not read by the Generator.

Multiple US patents and patent applications exist covering ostomy-pouch leak-detection sensing (e.g. "Ostomy monitoring system and method," "Ostomy leakage detection system," "Resistance sensor for identifying leak locations in ostomy system," and others located via web search), a body of art that bears on the sensor/notification competitive space (Heylo and similar) but not, as far as the Generator's search determined, on a non-absorptive mechanical valve device of this candidate's specific shape.

A device described as an "indwelling ileostomy valve device," using a Silastic tube with a circumferential balloon to provide a leakproof seal functionally replacing a failed nipple valve, was clinically studied in 14 patients and reported to maintain continuous, voluntary control over evacuation without adverse effects, published in 1980.

Mechanism/clinical-risk assumption (Generator's own reasoning, flagged as an assumption rather than a fact): a non-absorptive mechanical valve seated at the stoma orifice avoids the retained-intraluminal-foreign-body and bowel-obstruction risk profile that would attach to a device advanced into the proximal small bowel, but introduces its own failure modes — valve occlusion by particulate effluent, leakage past the valve seal, and skin/mucosal irritation at the retention collar — none of which have been characterized by any bench or animal study, because none has been performed; this device does not yet exist as a prototype.

Adults with a mature, uncomplicated (non-surgically-reconstructed) ileostomy would be willing to learn and perform daily self-insertion and self-removal of an intraluminal stoma valve, in exchange for reduced pouch bulk and reduced adhesive-related skin exposure.

WOC (wound/ostomy/continence) nurses and other prescribing clinicians would be willing to train and support ileostomy patients in self-insertion and self-removal of an intraluminal stoma valve, rather than treating it as an added training and liability burden relative to a conventional adhesive pouching system.

Ileostomy patients who currently experience pouch leakage and peristomal skin irritation would find a valve-and-cap collection interface preferable to their current adhesive pouching system beyond an initial trial period, sufficient to sustain continued daily use rather than reversion to pouching.

No HCPCS code, distinct from the existing A4361-A4438 adhesive-pouch billing category, currently exists that would allow Medicare DMEPOS billing for a valve-based, non-adhesive intraluminal stoma-collection device of this shape.

Ileostomy patients or their DME (durable medical equipment)/insurance payer would pay a price for this device sufficient to sustain a dedicated specialty manufacturing and distribution channel, above the commodity per-unit reimbursement rates that apply to conventional adhesive ostomy pouching supplies.

This device's silicone one-way valve and low-profile external cap could be manufactured, sterilized (or validated for safe patient reprocessing/reuse), and given a shelf life suitable for a patient-replaceable, daily-use home medical device, at a unit cost compatible with DMEPOS-scale ostomy-supply reimbursement rates.

An adult patient with a mature ileostomy could be trained to correctly size, self-insert, and self-remove this intraluminal valve device without clinician supervision after an initial training period, and without causing mucosal trauma, stomal stenosis, or valve misplacement.